The MOG Project (@TheMOGProject) header
The MOG Project (@TheMOGProject) profile picture

We collaborate with national & international Doctors & Researchers around the world to help educate & provide research about #MOGAD. 501(c)3 🌺 #ViewsAreOurOwn

United States
Joined April 2020
For clinicians: TIMELY-PLEX: Does early plasma exchange improve recovery after severe optic neuritis or myelitis? Refer within 14 days of symptom onset. See participating sites to refer patients at timely-plex.org The MOG Project serves as an advocacy principal investigator. NCT07100990: clinicaltrials.gov/study/NCT… #MOGAD
1
7
14
648
Welcome Dr. Haiwen Chen to The MOG Project’s Medical & Scientific Advisory Council! A pediatric neuroimmunologist at Johns Hopkins, Dr. Chen combines clinical MOGAD research with laboratory studies exploring how brain cells influence neuronal communication. Meet Dr. Chen: mogproject.org/medical-advis… #MOGAD
1
7
491
How does MOGAD affect daily life for children and families around the world? The global IMPACT Survey invites young people ages 12–20 with MOGAD and parents/guardians of those ages 0–20 to share their experiences. Anonymous. 20–30 min. Take part: redcap.link/impact-survey Sponsored by UCB.
1
1
3
527
A step forward for MOGAD: FDA granted Priority Review to Enspryng® (satralizumab) — potentially the first MOGAD treatment. Trial: 68% lower relapse risk vs placebo. FDA decision expected Jan 10 2027. gene.com/media/press-release…
2
3
1
11
592
Exciting collaboration ahead! đź’— Our Executive Director met with @Drjonsantoro, Chief of Neurology & Co-Director of the Neurological Institute at @ChildrensLA, to launch the first global pediatric #MOGAD survey and discuss new programs for 2027.
4
334
🚨 New MOGAD research published in JAMA Neurology! An international study found IL-6 receptor blockers (primarily tocilizumab) were associated with substantially lower relapse rates and a generally favorable safety profile, adding to the growing evidence for relapse prevention in MOGAD. Read more: jamanetwork.com/journals/jam… #MOGAD
1
15
715
Looking forward to seeing you all in Baltimore 🥰 We teased it a couple of months ago… and now it’s finally here: registration for the 2026 U.S. MOGAD Patient Summit is OPEN!! ✨ Join us August 29–30, 2026 in Baltimore, MD for a meaningful weekend of education, connection, advocacy, and community with patients, caregivers, clinicians, researchers, and families from across the MOGAD community. This year’s Summit will include: 🔹 Presentations from leading MOGAD experts 🔹 Research and clinical trial updates 🔹 Patient-centered sessions and discussions 🔹 Family-friendly programming and a Kids Zone 🔹 A celebratory dinner at the Maryland Science Center overlooking the Inner Harbor Conference sessions will take place at the Royal Sonesta Baltimore Inner Harbor, and a hotel room block will be available for attendees. Registration is FREE, but space is limited, so please only register if you genuinely intend to attend. We are not currently able to offer travel grants. Please register each person attending, including children. We are so excited to bring the community together again and hope to see you there! Register here: mogproject.org/Summit2026/
1
1
1
445
One of the strategic goals of The MOG Project, the leading global nonprofit organization wholly dedicated to MOGAD, is to ensure an arsenal of safe and effective treatments. Today, Hoffmann-La Roche and Genentech have helped to meet that goal! Enspryng® (satralizumab)'s new Phase III data show that: ➡️ Reduced new relapse risk by 68% compared to placebo in adults and adolescents ➡️ Enabled 87% of patients to remain relapse-free at 48 weeks (vs. 67% on placebo) ➡️ Significant reduction in inflammation that may reduce the use of steroids, plasma exchange or intravenous immunoglobulins ➡️ No new safety signals identified, and safety profile of Enspryng® was consistent with over a decade of use in another autoimmune disease ➡️ Hoffmann La-Roche and Genentech plan to present these data to regulatory authorities globally This is the kind of progress our community has been working toward -- data-driven, clinically meaningful, and centered on improving quality of life! Read our press release here: mogproject.org/enspryng-resu… MOGAD is a rare autoimmune disease of the central nervous system that can affect the optic nerve, spinal cord, and brain -- often leading to unpredictable and debilitating relapses.
2
2
348
Join the #EMSP2026 Conference in Berlin from 24–25 April with @eumsplatform. This year’s theme: From Diagnosis to Access: Data-Driven Solutions – Building a Fairer Future for Patients What to expect: -Cutting-edge clinical insights -High-level EU health policy discussions -Practical, patientcentered solutions -Networking with 100+ stakeholders from across Europe Whether you're a patient advocate, clinician, researcher, or policymaker — this is where priorities meet innovation. NH Hotel Berlin-Friedrichstraße, Register now: eu.eventscloud.com/website/1…
3
165
A historic moment for the MOGAD community! Positive Phase III results from the METEOROID clinical trial mark the first successful MOGAD treatment study—made possible by the participants and their families. As the pre-eminent global nonprofit for #MOGAD, The MOG Project calls this a “historic day” and applauds “Hoffmann-LaRoche/Genentech’s landmark achievement and their investment in finding new, safe, and effective treatments for MOGAD.” Learn more: mogproject.org/meteoroid
11
2
30
2,979
Just two wonderful Drs & beautiful souls who we’re fortunate enough to have on our Advisory board discussing all things #MOGAD & #Neuroimmunology at #ECTRIMS. @EthelScl & @dr_fiona_c 💕
3
2
10
802
We are thrilled to welcome Dr @Benjamin_Trewin with @JustJen_K to our ANZ Medical Advisory Board! Dr Ben is a Sydney-based neurologist & neuroimmunologist specialising in #MOGAD, #NMOSD & #MS. He is a clinician-scientist exploring relapse risk, treatment comparisons & long-term outcomes in autoimmune demyelination. Ben is committed to improving diagnosis, refining treatment strategies, & ensuring people living with autoimmune neurological disorders have access to individualised, evidence-based care. Read his full bio here 👉 mogproject.org/about/#trewin Welcome to the team 🧪🔬🥼👨🏻‍🔬
1
1
2
6
951
Look who we’ve poached with @JustJen_K to our ANZ Medical Advisory Council, @dr_fiona_c. Dr Fiona is Neurologist specialising in Neuro-Ophthalmology & Neuro-Immunology, with advanced clinical & research training across Australia, UK, & Oxford’s renowned #NMOSD & #MOGAD clinic. She is deeply committed to patient advocacy, education, & advancing care for rare neuroimmune disorders. Read her full bio here 👉 mogproject.org/medical-advis… Welcome to the team! 🔬👩🏻‍🔬🥼🧪
2
1
2
5
820